Kitonid Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections. Ketoconazole acts by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Kitonid Cream is indicated for the management of dermatophytosis, candidiasis, pityriasis versicolor, and seborrheic dermatitis involving the skin. The topical formulation allows for targeted application, minimizing systemic absorption and associated side effects. It is typically applied once or twice daily to the affected area after cleansing and drying the skin, with the duration of therapy depending on the severity and type of infection, usually ranging from 2 to 4 weeks. Common adverse effects are generally mild and may include local irritation, itching, or burning sensation at the site of application. Kitonid Cream should be used with caution in patients with known hypersensitivity to ketoconazole or any of the cream’s excipients. It is not recommended for use on mucous membranes or in systemic fungal infections. Patients are advised to complete the full course of treatment to prevent recurrence and resistance. Consultation with a healthcare professional is recommended prior to use to ensure appropriate diagnosis and therapy.